Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Akt
    (2)
  • Antibiotic
    (2)
  • Apoptosis
    (6)
  • Autophagy
    (3)
  • BCL
    (2)
  • ERK
    (2)
  • HIV Protease
    (2)
  • NF-κB
    (3)
  • TLR
    (2)
  • Others
    (26)
Filter
Search Result
Results for "

antitumor effect

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    56
    TargetMol | Activity
  • Compound Libraries
    3
    TargetMol | inventory
  • Inhibitory Antibodies
    2
    TargetMol | natural
  • PROTAC Products
    3
    TargetMol | composition
  • Natural Products
    18
    TargetMol | Activity
Trastuzumab deruxtecan
DS-8201a,VRN-101099,DS 8201,T-DXd
T366461826843-81-5
Trastuzumab deruxtecan (T-DXd) is an antibody-active molecule conjugate (ADC) with anticancer and antitumor activity, which is composed of a monoclonal antibody targeting human epidermal growth factor receptor 2 (HER2) coupled to a topoisomerase I inhibitor (DXd). Trastuzumab deruxtecan has an improved effect on the treatment of HER2-positive breast cancer and gastric cancer.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
Isatuximab
Isatuximab(anti-CD38),SAR-650984,hu38SB19,Isatuximab-irfc
T389511461640-62-9
Isatuximab is a monoclonal antibody targeting the transmembrane receptor and extracellular enzyme CD38 in malignant cells of the hematological system, a highly expressed protein in multiple myeloma. It exhibits antitumor activity, antibody-dependent cytotoxicity, complement-dependent cytotoxicity, and antibody-dependent cytophagocytosis, directly inducing apoptosis without crosslinking. Isatuximab inhibits CD38 extracellular enzyme activity, affecting various cellular functions.
    Inquiry